Person

Duncan McKechnie

EVP, Chief Commercial Officer, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$5.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 2, 2026VRTXSale1,541$519.00$800K
Mar 11, 2026VRTXSale2,633$498.42$1.3M
Mar 4, 2026VRTXSale2,437$475.30$1.2M
Feb 25, 2026VRTXSale2,410$489.00$1.2M
Feb 25, 2026VRTXSale2,500$486.35$1.2M

SEC reporting-owner ID (CIK) 2062139 · all filings on EDGAR

Duncan McKechnie (VRTX) | USBoard